$3.43
2.28% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$3.43
-3.89 53.14% 1M
-3.51 50.58% 6M
-5.78 62.76% YTD
-13.83 80.13% 1Y
-94.56 96.50% 3Y
-34.88 91.05% 5Y
-9.94 74.35% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.08 2.28%
ISIN
US14161W1053
Symbol
CDLX

Key metrics

Market capitalization $170.95m
Enterprise Value $321.68m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.05
P/S ratio (TTM) P/S ratio 0.56
P/B ratio (TTM) P/B ratio 0.81
Revenue growth (TTM) Revenue growth 3.10%
Revenue (TTM) Revenue $305.42m
EBIT (operating result TTM) EBIT $-58.49m
Free Cash Flow (TTM) Free Cash Flow $-10.32m
Cash position $71.25m
EPS (TTM) EPS $-3.83
P/E forward negative
P/S forward 0.65
EV/Sales forward 1.22
Short interest 20.76%
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Cardlytics, Inc. forecast:

4x Hold
80%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a Cardlytics, Inc. forecast:

Hold
80%
Sell
20%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
305 305
3% 3%
100%
- Direct Costs 167 167
9% 9%
55%
138 138
23% 23%
45%
- Selling and Administrative Expenses 118 118
8% 8%
39%
- Research and Development Expense 51 51
6% 6%
17%
-31 -31
56% 56%
-10%
- Depreciation and Amortization 27 27
20% 20%
9%
EBIT (Operating Income) EBIT -58 -58
44% 44%
-19%
Net Profit -153 -153
60% 60%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
GlobeNewsWire
2 days ago
SAN FRANCISCO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now . The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Neutral
GlobeNewsWire
9 days ago
SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Neutral
Accesswire
17 days ago
CDLX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / August 21, 2024 / Hagens Berman urges Cardlytics, Inc. (NASDAQ:CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 434
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today